ITHACA, N.Y.--(BUSINESS WIRE)--Rheonix Inc. announced today that the United States Food and Drug Administration (FDA) has issued an expanded Emergency Use Authorization (EUA) for the Rheonix COVID-19™ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback